Immunotherapy is the treatment of disease by enhancing, inducing or suppressing an immune response. It has gained great interest among researchers, clinicians and pharmaceutical companies, particularly in its promise to treat various forms of cancer. With thousands of patents filed annually on the subject, it is estimated that there are thousands of immunotherapy licensing opportunities across technology transfer offices that are in need of development and commercialization partners. Immunomodulatory regimens often have fewer side effects than existing drugs, including less potential for creating resistance when treating microbial disease